140 related articles for article (PubMed ID: 36482532)
1. A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance.
Shi N; Zhou Y; Ma H
Medicine (Baltimore); 2022 Dec; 101(48):e32057. PubMed ID: 36482532
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of modified Huanglian Wendan decoction in the treatment of polycystic ovary syndrome.
Wu Z; Yang T; Ma H
Medicine (Baltimore); 2023 Apr; 102(15):e33212. PubMed ID: 37058016
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
4. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
Yu J; Fu Y; Zeng L; Zheng Y
Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of
Wu M; Liu H; Zhang J; Dai F; Gong Y; Cheng Y
J Pharm Pharm Sci; 2023; 26():11234. PubMed ID: 36942296
[No Abstract] [Full Text] [Related]
6. Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2/HO-1/Cyp1b1 pathway: Integrating network pharmacology and experimental validation in vivo.
Zheng R; Shen H; Li J; Zhao J; Lu L; Hu M; Lin Z; Ma H; Tan H; Hu M; Li J
J Ethnopharmacol; 2023 Jan; 301():115824. PubMed ID: 36273747
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial.
Qian H; Xu W; Cui L; Wang R; Wang J; Tang M; Wei M; Wang L
Trials; 2021 Nov; 22(1):781. PubMed ID: 34743745
[TBL] [Abstract][Full Text] [Related]
8. The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments.
Hu W; Xie N; Zhu H; Jiang Y; Ding S; Ye S; Zhang S; Wang F; Qu F; Zhou J
J Pharm Biomed Anal; 2024 Feb; 239():115867. PubMed ID: 38061171
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology-based strategic prediction and target identification of apocarotenoids and carotenoids from standardized Kashmir saffron (Crocus sativus L.) extract against polycystic ovary syndrome.
Tiwari A; Modi SJ; Girme A; Hingorani L
Medicine (Baltimore); 2023 Aug; 102(32):e34514. PubMed ID: 37565925
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology.
Lin Y; Xiang L; Li X; Tang Q; Meng F; Chen W
Curr Med Chem; 2023; 30(21):2463-2474. PubMed ID: 35532255
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis- radix rehmanniae drug pair.
Li X; Ullah I; Hou C; Liu Y; Xiao K
Medicine (Baltimore); 2023 Nov; 102(46):e36118. PubMed ID: 37986355
[TBL] [Abstract][Full Text] [Related]
13. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
14. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
Ma K; Gong LJ; Chen YX; Tian CD
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of Shaofu Zhuyu Decoction in treatment of EMT induced dysmenorrhea based on network pharmacology and molecular docking].
Chen YH; Zhang ZL; Wu QS; Feng P; Qiao XY; Zhang XH; Mao HY; Cai S; Zhou XJ
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6484-6492. PubMed ID: 34994141
[TBL] [Abstract][Full Text] [Related]
16. Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome.
Xing J; Luo X; Jia K; Liu S; Chen S; Qiao G; Zhang C; Yi J
J Ovarian Res; 2023 Jul; 16(1):128. PubMed ID: 37393270
[TBL] [Abstract][Full Text] [Related]
17. Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking.
Yang L; Zheng S; Hou A; Wang S; Zhang J; Yu H; Wang X; Lan W
Medicine (Baltimore); 2022 Oct; 101(42):e31009. PubMed ID: 36281111
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets and mechanisms of
Wang YJ; Wang YL; Jiang XF; Li JE
World J Diabetes; 2023 Nov; 14(11):1659-1671. PubMed ID: 38077804
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
